December 17, 2020

2nd COVID-19 Vaccine Gets Public Review Ahead Of US Decision-The Associated Press

A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday as government advisers convened for a public review of its safety and effectiveness. It’s the next-to-last step for the vaccine developed by drugmaker Moderna and the National Institutes of Health. The panel of physicians and medical researchers is expected to endorse it, followed by the Food and Drug Administration’s OK within hours or days. The Associated Press, 12/17/2020